Japan To Give Regenerative-Medicine Products 25-Year Patent Protection
This article was originally published in PharmAsia News
Executive Summary
Japan is set to provide regenerative-medicine products the same 25-year protection now applied only to pharmaceutical and chemical products that face longer approval processes.